Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Exchange Rate Effect (2021 - 2024)

Seres Therapeutics (MCRB) has disclosed Exchange Rate Effect for 4 consecutive years, with -$1000.0 as the latest value for Q4 2024.

  • Quarterly Exchange Rate Effect changed N/A to -$1000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Sep 2024, up 300.0% year-over-year, with the annual reading at -$1000.0 for FY2024, 150.0% down from the prior year.
  • Exchange Rate Effect hit -$1000.0 in Q4 2024 for Seres Therapeutics, down from $1000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $1000.0 in Q4 2022 to a low of -$2000.0 in Q3 2022.
  • Historically, Exchange Rate Effect has averaged -$400.0 across 4 years, with a median of -$1000.0 in 2021.
  • Biggest five-year swings in Exchange Rate Effect: skyrocketed 200.0% in 2022 and later surged 150.0% in 2023.
  • Year by year, Exchange Rate Effect stood at -$1000.0 in 2021, then surged by 200.0% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then crashed by 200.0% to -$1000.0 in 2024.
  • Business Quant data shows Exchange Rate Effect for MCRB at -$1000.0 in Q4 2024, $1000.0 in Q3 2023, and $1000.0 in Q4 2022.